DRKS00014827已完成不适用
Post Market Clinical Follow-up, retrospective and prospective, observational Study of the IP Medical Vein Stent: blueflow Venous Stent - blueflow PMCF
IP Medical GmbH0 个研究点目标入组 61 人开始时间: 2018年6月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 61
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •All patients >18 years with:
- •Residual thrombosis of iliofemoral veins and/or inferior vena cava after thrombus removal (by catheter-directed or pharmacomechanical thrombolysis)
- •Post-thrombotic syndrome and chronic obstruction of iliofemoral veins and/or inferior vena cava
- •Chronic venous insufficiency and presence of non-thrombotic venous stenosis of iliofemoral veins and/or inferior vena cava
排除标准
- •Age < 18 years
- •No consent
- •Inability to provide informed consent
- •Allergy to Nitinol
- •Pregnancy, breast-feeding or birth giving during the last 30 days
- •Life expectancy <3 months
研究者
相似试验
已完成
不适用
on-interventional Post-Market Clinical Follow-up Study to endorse performance and safety of Weiche Nasensalbe nach Dr. Bader® for moistening the dry nasal mucosa in the anterior area of the noseDry nose and/or nasal mucosaDRKS00032964Hälsa Pharma GmbH50
尚未招募
4 期
To evaluate the safety and performance of facial bone plates and time taken in bone union.CTRI/2024/07/070241Auxein Medical Pvt Ltd
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations- Hypromellose plus Sodium Hyaluronate Eye Drops.CTRI/2022/07/043789STERICON PHARMA PRIVATE LIMITED54
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations - HPMC EYE WASH (Hydroxy Propyl Methyl Cellulose Eye Wash )CTRI/2022/07/043794STERICON PHARMA PRIVATE LIMITED72
已完成
4 期
A post market clinical follow up study of Sodium Hyaluronate 0.2% Eye DropsCTRI/2024/02/062929Amanta Healthcare Limited54